Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1984 Dec;53(4):611–621.

Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells.

G Gallagher, W H Stimson
PMCID: PMC1454883  PMID: 6209205

Abstract

Human T-cell hybrids were constructed from an HGPRT-negative mutant of the acute lymphoblastoid leukaemia cell-line CEM and an uncloned population of T cells from donor SW (SW-T; partner cell) known to have a strong specificity for the autologous Epstein-Barr virus (EBV)-transformed B cell, SWEBV. The resulting hybrids, 1A9, 1D12 and 2C8, were shown not to be cytotoxic to SWEBV, nor did they have natural killer-like (NK) activity. However, when presented with the target SWEBV in a mixed lymphocyte reaction (MLR), all of the hybrids rapidly increased their rate of proliferation by up to a factor of seven. Hybrid 1D12 also produced interleukin-2-like material (IL2) under these conditions. The hybrids did not react with the autologous PHA-blasts (SWPHA), nor with various unrelated targets. When tested against a bank of EBV-transformed B-cell targets, it was observed that the human T-cell hybrids 1A9 and 2C8 responded only to those targets bearing the antigen HLA Bw35. This response could be blocked by treating the target with the monoclonal antibody W6/32, specific for a shared determinant of the HLA-A, -B and -C antigens. Similarly, the human T-cell hybrid 1D12 reacted only against those targets bearing the antigen HLA DrW2, and this activity could be blocked by the monoclonal antibody DA6.231, specific for a common region of the HLA-DR and SB antigens. Thus, human T-cell hybrids can be produced which exhibit HLA-restricted responses to antigenic stimulation.

Full text

PDF
611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DeFreitas E. C., Vella S., Linnenbach A., Zmijewski C., Koprowski H., Croce C. M. Antigen-specific human T-cell hybridomas with helper activity. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6646–6650. doi: 10.1073/pnas.79.21.6646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gallagher G., Stimson W. H. Generation of human T-cell hybrids with the characteristics of human peripheral blood T-lymphocytes. Immunol Lett. 1983 Apr;6(4):203–207. doi: 10.1016/0165-2478(83)90004-4. [DOI] [PubMed] [Google Scholar]
  3. Issekutz T., Chu E., Geha R. S. Antigen presentation by human B cells: T cell proliferation induced by Epstein Barr virus B lymphoblastoid cells. J Immunol. 1982 Oct;129(4):1446–1450. [PubMed] [Google Scholar]
  4. Kobayashi Y., Asada M., Higuchi M., Osawa T. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor. J Immunol. 1982 Jun;128(6):2714–2718. [PubMed] [Google Scholar]
  5. Lakow E. S., Valentine M. A., Vaughan J. H., Tsoukas C. D., Carson D. A. Effects of monoclonal antibodies against lymphocyte surface antigens on interleukin 2 excretion by Epstein-Barr virus-specific human T-cell hybridomas. Cell Immunol. 1984 Apr 15;85(1):67–74. doi: 10.1016/0008-8749(84)90278-8. [DOI] [PubMed] [Google Scholar]
  6. Lakow E., Tsoukas C. D., Vaughan J. H., Altman A., Carson D. A. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes. J Immunol. 1983 Jan;130(1):169–172. [PubMed] [Google Scholar]
  7. Lamb J. R., Eckels D. D., Lake P., Johnson A. H., Hartzman R. J., Woody J. N. Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. J Immunol. 1982 Jan;128(1):233–238. [PubMed] [Google Scholar]
  8. Lamb J. R., Fledmann M. A human suppressor T cell clone which recognizes an autologous helper T cell clone. Nature. 1982 Dec 2;300(5891):456–458. doi: 10.1038/300456a0. [DOI] [PubMed] [Google Scholar]
  9. Meuer S. C., Cooper D. A., Hodgdon J. C., Hussey R. E., Morimoto C., Schlossman S. F., Reinherz E. L. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations. J Immunol. 1983 Sep;131(3):1167–1172. [PubMed] [Google Scholar]
  10. Meuer S. C., Schlossman S. F., Reinherz E. L. Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. Proc Natl Acad Sci U S A. 1982 Jul;79(14):4395–4399. doi: 10.1073/pnas.79.14.4395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Moretta L., Mingari M. C., Sekaly P. R., Moretta A., Chapuis B., Cerottini J. C. Surface markers of cloned human T cells with various cytolytic activities. J Exp Med. 1981 Aug 1;154(2):569–574. doi: 10.1084/jem.154.2.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moss D. J., Rickinson A. B., Wallace L. E., Epstein M. A. Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation. Nature. 1981 Jun 25;291(5817):664–666. doi: 10.1038/291664a0. [DOI] [PubMed] [Google Scholar]
  13. Moss D. J., Wallace L. E., Rickinson A. B., Epstein M. A. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro. Eur J Immunol. 1981 Sep;11(9):686–693. doi: 10.1002/eji.1830110904. [DOI] [PubMed] [Google Scholar]
  14. Okada M., Yoshimura N., Kaieda T., Yamamura Y., Kishimoto T. Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7717–7721. doi: 10.1073/pnas.78.12.7717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rabin H., Hopkins R. F., 3rd, Ruscetti F. W., Neubauer R. H., Brown R. L., Kawakami T. G. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J Immunol. 1981 Nov;127(5):1852–1856. [PubMed] [Google Scholar]
  16. Wallace L. E., Moss D. J., Rickinson A. B., McMichael A. J., Epstein M. A. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants. Eur J Immunol. 1981 Sep;11(9):694–699. doi: 10.1002/eji.1830110905. [DOI] [PubMed] [Google Scholar]
  17. Wallace L. E., Rickinson A. B., Rowe M., Epstein M. A. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature. 1982 Jun 3;297(5865):413–415. doi: 10.1038/297413a0. [DOI] [PubMed] [Google Scholar]
  18. Wee S. L., Chen L. K., Strassmann G., Bach F. H. Helper cell-independent cytotoxic clones in man. J Exp Med. 1982 Dec 1;156(6):1854–1859. doi: 10.1084/jem.156.6.1854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zanders E. D., Lamb J. R., Feldmann M., Green N., Beverley P. C. Tolerance of T-cell clones is associated with membrane antigen changes. Nature. 1983 Jun 16;303(5918):625–627. doi: 10.1038/303625a0. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES